
285: CRISPR history, biotech struggles, & a big week for deals
The Readout Loud
Discussion on Atlas's performance and acquisitions in the obesity space
A discussion on the performance of Atlas throughout the year, including the acquisition of their obesity-focused companies by other organizations. They also highlight the successful acquisition of Nimbus's TIC2 program by TICADA and Versa. The chapter concludes with gratitude for the guest and contact information for feedback.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.